Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing
International Journal of Molecular Sciences · 27.11.2023 · 24 (23) · 16798
DOI: 10.3390/ijms242316798 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.11.2023. Verfasst von Vladlena S Makeeva und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, 10 Akad. Lavrentiev Ave., 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Huntington Disease, Neurodegenerative Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 233 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
The spectrum of neurodegenerative diseases known today is quite extensive. The complexities of their research and treatment lie not only in their diversity. Even many years of struggle and narrowly focused research on common pathologies such as Alzheimer’s, Parkinson’s, and other brain diseases have not brought cures for these illnesses. What can be said about orphan diseases? In particular, Huntington’s disease (HD), despite affecting a smaller part of the human population, still attracts many researchers. This disorder is known to result from a mutation in the HTT gene, but having this information still does not simplify the task of drug development and studying the mechanisms of disease progression. Nonetheless, the data accumulated over the years and their analysis provide a good basis for further research. Here, we review studies devoted to understanding the mechanisms of HD. We analyze genes and molecular pathways involved in HD pathogenesis to describe the action of repurposed drugs and try to find new therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cytology and Genetics, Siberian Branch of Russian Academy of Sciences, 10 Akad. Lavrentiev Ave., 630090 Novosibirsk, Russia.
- Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of Russian Academy of Sciences, 8 Akad. Lavrentiev Ave., 630090 Novosibirsk, Russia.
ORCID-Profile: Nadezhda S Dyrkheeva, Olga I Lavrik, Anastasia A Malakhova
Förderung
- Russian Science Foundation
Zitieren
APA
Makeeva, V. S., Dyrkheeva, N. S., Lavrik, O. I., Zakian, S. M., & Malakhova, A. A. (2023). Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing. International Journal of Molecular Sciences, 24(23), 16798. https://doi.org/10.3390/ijms242316798
Vancouver
Makeeva VS, Dyrkheeva NS, Lavrik OI, Zakian SM, Malakhova AA. Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing. International Journal of Molecular Sciences. 2023;24(23):16798. doi:10.3390/ijms242316798
BibTeX
@article{Makeeva2023,
author = {Makeeva, Vladlena S and Dyrkheeva, Nadezhda S and Lavrik, Olga I and Zakian, Suren M and Malakhova, Anastasia A},
title = {Mutant-Huntingtin Molecular Pathways Elucidate New Targets for Drug Repurposing},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {23},
pages = {16798},
doi = {10.3390/ijms242316798}
}
EUVIMED